The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adverse prognostic impact of heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma (EAC).
Harry H. Yoon
Honoraria - Roche/Genentech
Research Funding - Roche/Genentech
Qian Shi
No relevant relationships to disclose
William R. Sukov
No relevant relationships to disclose
Christopher A. Sattler
No relevant relationships to disclose
Anne E. Wiktor
No relevant relationships to disclose
Tsung-Teh Wu
No relevant relationships to disclose
Robert B. Diasio
No relevant relationships to disclose
Robert B. Jenkins
No relevant relationships to disclose
Frank A. Sinicrope
No relevant relationships to disclose